AstraZeneca PLC said Saturday clinical trials for its experimental coronavirus vaccine have resumed in the U.K. after regulators concluded it was safe to do so, following a pause in studies globally after a person who received the vaccine had an unexplained illness.
Trials in other countries, including the U.S., remain paused while AstraZeneca works with national health authorities, the company said.
AstraZeneca…
